HOME >> BIOLOGY >> NEWS
Malaria research and training benefits global community

NATIONAL INSTITUTES OF HEALTH, BETHESDA, MD - Malaria kills 2.7 million people each year, according to the most recent estimates, and is responsible for enormous economic burdens in malaria-endemic regions. Ninety percent of those who die of malaria are African children under the age of 5. Over 1.5 billion new infections occur annually. Unfortunately, these numbers are on the rise due to insecticide resistance, antimalarial drug resistance, and environmental changes. Unless new strategies are developed, death and illness due to malaria will increase, and the disease will continue to be a substantial barrier to the economic and social development of malaria-endemic regions and a threat to the millions of people who travel to those regions each year.

In 1997, an international alliance of research and public health agencies and African scientists launched the Multilateral Initiative on Malaria (MIM). MIM is stimulating collaborative research to answer the needs of public health programs in malaria-endemic countries, modernizing communication systems used by the African research community, and strengthening research capacity and human resources where malaria takes its greatest toll - sub-Saharan Africa. MIM supports 23 collaborative malaria research projects between African laboratories that are also in partnership with laboratories in Europe and the United States. Detailed information about MIM, its partners, and activities is available on the MIM website at http://mim.nih.gov.

April 25, 2001 is the first-ever Africa Malaria Day. Today, MIM is announcing two international conferences on malaria. MIM will hold the Third MIM Pan-African Conference on Malaria from November 18 to 22, 2002, in Arusha, Tanzania. This conference will bring together malaria researchers who battle Plasmodium falciparum malaria, which causes the most severe illness and which is the dominant form of malaria in sub-Saharan Africa. In additio
'"/>

Contact: Jennifer Cabe
jennifercabe@nih.gov
301-496-2075
NIH/Fogarty International Center
24-Apr-2001


Page: 1 2 3 4

Related biology news :

1. GenVec, U.S. NMRC, and PATHs Malaria Vaccine Initiative partner to expand malaria vaccine efforts
2. Malaria rise in Africa parallels warming trends
3. Pan-African Malaria Conference November 17-22 in Arusha, Tanzania
4. Multilateral Initiative on Malaria Secretariat to move to Sweden
5. Malaria called failure, puzzle and challenge
6. Multicomponent Malaria Vaccine Shows Promise in Laboratory Tests
7. Christmas Travellers Are Warned Of Malaria Risks
8. Genetic Code Of Chromosome Of Malaria Parasite Deciphered
9. Virginia Tech Scientist Seek Genetic Solution To Malaria
10. Severe Falciparum Malaria Increases In Honduras
11. Curing Malaria, Controlling Mosquitoes Symposium Set For AAAS Meeting

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:7/10/2020)... ... July 08, 2020 , ... ... and Gene Therapy Regulation, An FDAnews Webinar, Wednesday, July 22, 2020 • 1:30 ... study, but what is the most effective way to complete one? Will the ...
(Date:7/1/2020)... ... July 01, 2020 , ... Catalent, a global leader ... Teva-Takeda Pharmaceuticals’ packaging facility in Minakuchi, located in the Shiga prefecture of Japan. ... in Kakegawa, the new 60,000-square-foot facility will provide customers with flexible clinical supply ...
(Date:6/23/2020)... (PRWEB) , ... June 23, ... ... provider of gene-to-protein and monoclonal antibody development services, today announced that the ... products and services to the pharmaceutical, diagnostics, and research industries. The decision ...
Breaking Biology News(10 mins):
(Date:7/18/2020)... ... July 16, 2020 , ... “We are thrilled to deliver this ... the only technology of its kind on the market and we were pleased that ... protective capacity of traditional cultured ingredients, creating a natural way to extend the shelf ...
(Date:7/18/2020)... (PRWEB) , ... July 17, 2020 , ... ... global consulting firm for the life sciences and food industries, is pleased to ... Director of Clinical Research – Business Development. , Charles is an accomplished and ...
(Date:7/10/2020)... ... July 09, 2020 , ... PathSensors Inc., ... has expanded the company’s exclusive license to include clinical applications for CANARY™ ... market, focusing initially on the SARS-CoV-2 biosensor. CANARY’s™ fast and highly ...
(Date:7/10/2020)... ... July 09, 2020 , ... Sentien Biotechnologies, Inc., ... hiring of Allen R. Nissenson, M.D., F.A.C.P., as its Chief Medical Officer. ... Sentien’s lead product, SBI-101. Dr. Nissenson serves as an Emeritus Professor of ...
Breaking Biology Technology:
Cached News: